Latest in Advocacy

  • Just Announced: More Affordable Insulin Options for Medicare Beneficiaries Coming Soon

    May 26, 2020

    JDRF welcomes the May 26th announcement by the Centers for Medicare & Medicaid Services about more affordable insulin options for people in the Medicare program.

  • Insulin Affordability Matters: Advocating to Make Insulin More Affordable for All

    November 14, 2019

    More than 1.25 million Americans live with type 1 diabetes (T1D), and this number continues to grow. They need insulin several times...

  • Enhanced Charitable Giving Incentives Explained: What it Means for Donors in 2020

    April 23, 2020

    What the federal economic relief package, also known as the CARES Act (Coronavirus Aid, Relief, and Economic Security) means for donors to JDRF.

  • New JDRF-Funded Study finds Lifetime T1D Management Costs a Collective $813 Billion

    February 24, 2020

    Cost for each diagnosed American is nearly $500,000.

  • FDA Approves Xeris Pharmaceuticals’ Glucagon to Treat Severe Hypoglycemia

    September 11, 2019

    “The approval of the GVOKE HypoPenTM is an important step forward for people with diabetes. Severe hypoglycemia is a terrifying and dangerous...

  • Testimony of Dr. Aaron Kowalski, Chief Mission Officer, JDRF House Energy & Commerce Committee Oversight And Investigations Subcommittee

    April 2, 2019

    ‘PRICED OUT OF A LIFESAVING DRUG: THE HUMAN IMPACT OF RISING INSULIN COSTS’ Chairwoman DeGette, Ranking Member Guthrie, Chairman Pallone, Ranking Member...

  • In a Step Backward, UnitedHealthcare Changes Policy to Limit Insulin Pumps for Children

    February 4, 2019

    On February 1, 2019, UnitedHealthcare (UHC) announced a significant change to its insulin pump coverage policy, as it will no longer cover...